Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course

Código QR

Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course

Background. The use of atypical antipsychotics in schizophrenia contributes to the reduction of psychotic, affective, negative and cognitive disorders.Aims. To evaluate the effectiveness of ziprasidone therapy in patients with schizoaffective disorder and paranoid schizophrenia with episodic course....

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	L. A. Ivanova, O. P. Vorsina, T. A. Eliseeva, K. A. Frolovа, E. V. Sapozhnikova
Formato:	article
Lenguaje:	RU
Publicado:	Scientific Сentre for Family Health and Human Reproduction Problems 2019
Materias:	schizoaffective disorder schizophrenia ziprasidone Science Q
Acceso en línea:	https://doaj.org/article/70ad0fb5d56344a5be659d884e219320
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
por: Sajatovic M, et al.
Publicado: (2018)

Patterns of Thyroid Hormone Prescription in Patients with Bipolar or Schizoaffective Disorder: Findings from the LiSIE Retrospective Cohort Study
por: Ingrid Lieber, et al.
Publicado: (2021)

Immunoinflammatory Profile in Patients with Episodic and Continuous Paranoid Schizophrenia
por: Irina K. Malashenkova, et al.
Publicado: (2021)

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2020)

Psychopharmacotherapy of Suicidal Behavior in Schizophrenia and Schizophrenic Spectrum Disorders
por: L. A. Ivanova
Publicado: (2020)

Measuring Emotional Awareness in Patients With Schizophrenia and Schizoaffective Disorders
por: Eva Maaßen, et al.
Publicado: (2021)

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1
por: Sajatovic M, et al.
Publicado: (2018)

Clinical schizophrenia & related psychoses
Publicado: (2007)

Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
por: Leonid Mikhaylovich Bardenshteyn, et al.
Publicado: (2010)

Reaction Time and Visual Memory in Connection to Hazardous Drinking Polygenic Scores in Schizophrenia, Schizoaffective Disorder and Bipolar Disorder
por: Atiqul Haq Mazumder, et al.
Publicado: (2021)

Complete agenesis of the corpus callosum in paranoid schizophrenia—a case report
por: Hari Neupane, et al.
Publicado: (2021)

Association of carbohydrate and fatty acid intake with anthropometric parameters in subjects with schizophrenia and bipolar disorders
por: Santillana T,Natalia, et al.
Publicado: (2016)

Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis
por: Sapunar Z,Jorge, et al.
Publicado: (2009)

Revisiting the Concepts of Secondary Schizophrenia and Pseudoschizophrenia
por: João Gama Marques
Publicado: (2021)

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
por: Ichinose M, et al.
Publicado: (2021)

Aberrant Learned Irrelevance in Patients with First-Episode Schizophrenia-Spectrum Disorder
por: Ryan Sai-Ting Chu, et al.
Publicado: (2021)

Congruency and phenotypic plasticity of immune and nervous systems in children with autism spectrum disorders compared to schizophrenia spectrum disorders”, Medical Immunology (Russia)
por: A. L. Burmistrova, et al.
Publicado: (2020)

Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders
por: Grambal A, et al.
Publicado: (2016)

Affective theory of the mind and suicide in women with borderline personality disorder and schizophrenia: a comparative study
por: Moustafa Mohamed Mohamed Abdo, et al.
Publicado: (2021)

Schizophrenia and sleep disorders: links, risks, and management challenges
por: Kaskie RE, et al.
Publicado: (2017)

Identification of Rare Mutations of Two Presynaptic Cytomatrix Genes <i>BSN</i> and <i>PCLO</i> in Schizophrenia and Bipolar Disorder
por: Chia-Hsiang Chen, et al.
Publicado: (2021)

Schizophrenia research and treatment

Schizophrenia research
Publicado: (1988)

Effective Connectivity between Major Nodes of the Limbic System, Salience and Frontoparietal Networks Differentiates Schizophrenia and Mood Disorders from Healthy Controls
por: Sevdalina Kandilarova, et al.
Publicado: (2021)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Borjanka Batinic, et al.
Publicado: (2021)

Eye Movements and Cognitive Functioning in Patients With Schizophrenia Spectrum Disorders: Network Analysis
por: Alexander Shmukler, et al.
Publicado: (2021)

Pattern of burden on the family of patients with schizophrenia and bipolar disorder: A comparative study
por: Khurshida Khatoon, et al.
Publicado: (2021)

Disordered Eating among People with Schizophrenia Spectrum Disorders: A Systematic Review
por: Anoop Sankaranarayanan, et al.
Publicado: (2021)

Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia
por: Puspitasari IM, et al.
Publicado: (2020)

Characteristics of auditory hallucinations in Indian patients with schizophrenia and bipolar affective disorder
por: Rajesh S Dhakne, et al.
Publicado: (2021)

Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
por: Matei VP, et al.
Publicado: (2020)

The Evolution of Approaches to Schizophrenia Diagnostics: from Kraepelin to ICD-11
por: Alexander B. Shmukler
Publicado: (2021)

First Episode Psychosis and Schizophrenia Are Systemic Neuro-Immune Disorders Triggered by a Biotic Stimulus in Individuals with Reduced Immune Regulation and Neuroprotection
por: Michael Maes, et al.
Publicado: (2021)

Combination therapy or monotherapy for the depressed type of schizoaffective disorder
por: Lubomira Iz&aacute;kov&aacute;, et al.
Publicado: (2009)

A Short Course Computer-assisted Cognitive Remediation in Patients with Schizophrenia Spectrum Disorders: A Randomized Clinical Trial
por: Samira Hatami, et al.
Publicado: (2021)

Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
por: Suguru Nakajima, et al.
Publicado: (2021)

Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis
por: Bracha Erlanger Avigdor, et al.
Publicado: (2021)

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
por: Ping Yin, et al.
Publicado: (2021)

Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
por: Iancu I, et al.
Publicado: (2015)

Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders – a cross-sectional study
por: Holubova M, et al.
Publicado: (2016)